Celularity Inc
For the period ended Dec 31, 2023. Filed Jul 30, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Jul 30, 2024
CELU$0.71-6.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Income (Loss)
| Year Ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Net revenues: | ||
| Product sales | $13,149 | $3,749 |
| Services | 5,441 | 5,512 |
| License, royalty and other | 4,181 | 8,714 |
| Total revenues | 22,771 | 17,975 |
| Operating expenses: | ||
| Cost of revenues (excluding amortization of acquired intangible assets) | ||
| Product sales | 8,628 | 2,353 |
| Services | 1,650 | 3,536 |
| License, royalty and other | 5,738 | 13,776 |
| Research and development | 30,465 | 78,363 |
| Selling, general and administrative | 50,576 | 66,021 |
| Change in fair value of contingent consideration liability | (104,339) | (126,277) |
| Goodwill impairment | 112,347 | 3,610 |
| IPR&D impairment | 107,800 | — |
| Amortization of acquired intangible assets | 2,193 | 2,193 |
| Total operating expenses | 215,058 | 43,575 |
| Loss from operations | (192,287) | (25,600) |
| Other income (expense): | ||
| Interest income | 320 | 365 |
| Interest expense | (3,015) | — |
| Change in fair value of warrant liabilities | 6,164 | 42,109 |
| Change in fair value of debt | (1,177) | (2,522) |
| Other income (expense), net | (6,290) | (147) |
| Total other income | (3,998) | 39,805 |
| Net (loss) income before income taxes | (196,285) | 14,205 |
| Income tax expense | 10 | 13 |
| Net (loss) income | $(196,295) | $14,192 |
| Change in fair value of debt due to change in credit risk, net of tax | 146 | 9 |
| Other comprehensive income | 146 | 9 |
| Comprehensive (loss) income | $(196,149) | $14,201 |
| Share information: | ||
| Net (loss) income per share – basic | $(11.02) | $1.01 |
| Weighted average shares outstanding – basic | 17,813,044 | 13,990,703 |
| Net (loss) income per share – diluted | $(11.02) | $0.95 |
| Weighted average shares outstanding – diluted | 17,813,044 | 14,983,002 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.